Novartis AG NVS

$ 104.21 0.36%

Annual report 2023
added 11-16-2024

Novartis AG Balance Sheet 2011-2024 | NVS

Annual Balance Sheet Novartis AG

	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	16.9 B	9.49 B	18.8 B	19.6 B	16.7 B	17.2 B	7.34 B	11.3 B	14.2 B	16.5 B
Long Term Debt	-	-	-	26.3 B	20.4 B	22.5 B	23.2 B	17.9 B	16.3 B	13.8 B	11.2 B	13.8 B	13.9 B
Long Term Debt Current	230 M	251 M	275 M	286 M	246 M	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	42.3 B	34.6 B	37.3 B	35.4 B	33 B	30.7 B	27.6 B	25.4 B	30.9 B	28.4 B
Total Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	53.2 B	58 B	64 B	71.1 B	62.8 B	66.9 B	58.9 B	55.2 B	54.4 B	54.5 B	51.8 B	55 B	51.6 B
Deferred Revenue	-	-	-	56 M	114 M	236 M	305 M	287 M	385 M	329 M	70 M	71 M	70 M
Retained Earnings	-	-	-	-	-	-	-	-	-	-	-	-	64.9 B
Total Assets	99.9 B	117 B	132 B	128 B	118 B	146 B	133 B	130 B	132 B	125 B	126 B	124 B	117 B
Cash and Cash Equivalents	13.4 B	7.52 B	12.4 B	9.66 B	11.1 B	13.3 B	8.86 B	7.01 B	-	-	-	-	-
Book Value	46.8 B	59.4 B	67.8 B	56.7 B	55.6 B	78.7 B	74.2 B	74.9 B	77.1 B	70.8 B	74.5 B	69.2 B	65.9 B
Total Shareholders Equity	-	-	-	56.7 B	55.6 B	78.7 B	-	74.9 B	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Novartis AG

	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	1.55 B	-	1.62 B	-	1.66 B	-	1.72 B	-	1.7 B	-	1.7 B	-	1.75 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	32.3 B	-	33.8 B	-	40.3 B	-	38.1 B	-	40.5 B	-	34.6 B	-	34.7 B	-	37.3 B	-	37.2 B	-	35.4 B	-	-	-	33 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	-	-	59.9 B	-	64 B	-	69.9 B	-	71.1 B	-	69.9 B	-	62.8 B	-	64.8 B	-	66.9 B	-	65.2 B	-	58.9 B	-	-	-	55.2 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	-	-	123 B	-	132 B	-	124 B	-	128 B	-	124 B	-	118 B	-	116 B	-	146 B	-	142 B	-	133 B	-	-	-	130 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	-	-	3.62 B	13.9 B	12.4 B	-	5.12 B	3.8 B	9.66 B	-	5.92 B	4.53 B	11.1 B	-	9.99 B	6.81 B	13.3 B	-	12.4 B	5.81 B	8.86 B	-	7.86 B	7.57 B	7.01 B	-	-	-	4.67 B	-	-	-	13 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	-	-	63 B	-	67.8 B	-	54.1 B	-	56.7 B	-	53.9 B	-	55.6 B	-	51.5 B	-	78.7 B	-	76.9 B	-	74.2 B	-	-	-	74.9 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-	-	63 B	61.7 B	67.8 B	-	54.1 B	50.6 B	56.7 B	-	53.9 B	51 B	55.6 B	-	51.5 B	47.3 B	78.7 B	-	76.9 B	71.2 B	74.2 B	-	70 B	67.6 B	74.9 B	-	-	-	77.1 B	-	-	-	70.8 B	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency